PVCT news............
KNOXVILLE, Tenn., Nov 18, 2003 /PRNewswire-FirstCall via Comtex/ --
Provectus Pharmaceuticals (OTC Bulletin Board: PVCT) announced today that the Company is aggressively working to correct erroneous reporting, by individuals, of the increase in the number of free-trading common shares. Reports have been circulated that as many as 1,593,752 more shares have been converted from restricted to free trading shares since September 24, 2003. This number is not correct. Examination of correct SEC filings currently available to the company (Form 144) indicate that between September 24, 2003 and November 17, 2003, only 283,752 shares have been converted from restricted to free trading shares by shareholders.
'It appears that mistakes may have been made by brokers or shareholders as private stockholder's shares were moved to new brokerage accounts, with the holdings being listed as free trading when, in fact, they were not,'said Provectus CEO Dr. Craig Dees. 'We are working directly with the brokers and shareholders to correct any mistakes.'
Provectus Pharmaceuticals, Inc. develops pharmaceutical products in three sectors of the health-care industry: 1) prescription medications, 2) medical devices, and 3) OTC pharmaceuticals and cosmetics. Prescription drug products and devices treat diseases of the skin and many types of cancer. OTC products address complementary markets, primarily those involving skin care and comfort.
The company's corporate offices and laboratory are located at 7327 Oak Ridge Highway, Suite A, Knoxville, Tenn. 37931; 865/769-4012. For more information, contact the company at info@pvct.com or visit the corporate Web site: www.pvct.com
"Aim low Sheriff...They're ride'n snakes"
as usual...JMHO..SMD
AI
